Neuronetics, Inc. (NASDAQ:STIM) Director Robert Cascella Acquires 50,000 Shares

Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella acquired 50,000 shares of the firm’s stock in a transaction on Thursday, June 6th. The shares were bought at an average cost of $2.05 per share, with a total value of $102,500.00. Following the completion of the transaction, the director now directly owns 244,098 shares […]

Related Keywords

United States ,William Blair ,Robert Cascella ,Piper Sandler ,Investment Advisers ,Davidj Yvars Group ,Kent Lake Capital ,Securities Exchange Commission ,First Eagle Investment Management ,Nasdaq ,Cannell Capital ,Neuronetics Inc ,Get Free Report ,Director Robert Cascella ,Exchange Commission ,Eagle Investment Management ,Lake Capital ,Neurostar Advanced Therapy System ,Neuronetics Daily ,